Literature DB >> 21727092

Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43.

Xun Ai1, Aiyang Jiang, Yunbo Ke, R John Solaro, Steven M Pogwizd.   

Abstract

AIMS: We previously showed decreased cellular coupling and dephosphorylation of the gap junctional protein connexin 43 (Cx43) in left ventricular (LV) myocytes from an arrhythmogenic rabbit model of non-ischaemic heart failure (HF) that was associated with a 2.5-fold increase in the amount of protein phosphatase type 2A (PP2A) co-localized with Cx43. Here, we further explore the molecular mechanisms of enhanced dephosphorylation of Cx43 in HF. p21-activated kinase 1 (PAK1) is a serine-threonine protein kinase that has been shown to activate PP2A. METHODS AND
RESULTS: We found that total PAK1 and activated PAK1 (PAK1-P(Thr423)) were both increased in HF rabbit LV (vs. controls). PAK1 co-immunoprecipitated (co-IP'd) with Cx43 protein and, with HF, co-IP'd PAK1 and PAK1-P(Thr423) were increased. With failing human LV, PAK1 total protein and PAK1-P(Thr423) were also increased globally and locally (co-IP'd with Cx43). To further explore the role of PAK1 in modulating Cx43 dephosphorylation and intercellular coupling, we overexpressed active PAK1 in isolated LV myocytes from control rabbits and in HEK293 cells with genetically modified overexpression of Cx43 (HEK293-Cx43). PAK1 overexpression in both rabbit myocytes and HEK293-Cx43 cells significantly increased PP2A activity (globally and at the level of Cx43), increased dephosphorylated Cx43, and markedly reduced intercellular dye coupling. These effects were attenuated with PP2A inhibition using okadaic acid (10 nM).
CONCLUSIONS: PAK1 and PP2A are integral components of a macromolecular complex with cardiac Cx43, and increased activation of associated PAK1 can contribute to enhanced Cx43 dephosphorylation and impaired intercellular coupling that may underlie slow conduction in HF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21727092      PMCID: PMC3172982          DOI: 10.1093/cvr/cvr163

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  40 in total

1.  Emerging from the Pak: the p21-activated protein kinase family.

Authors:  M A Sells; J Chernoff
Journal:  Trends Cell Biol       Date:  1997-04       Impact factor: 20.808

2.  Altered connexin expression in human congestive heart failure.

Authors:  E Dupont; T Matsushita; R A Kaba; C Vozzi; S R Coppen; N Khan; R Kaprielian; M H Yacoub; N J Severs
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

3.  Sudden unexpected death in patients with congestive heart failure: a second frontier.

Authors:  M Packer
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

Review 4.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

5.  Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy.

Authors:  K P Anderson; R Walker; P Urie; P R Ershler; R L Lux; S V Karwandee
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Connexin43 knockdown or overexpression modulates cell coupling in control and failing rabbit left ventricular myocytes.

Authors:  Xun Ai; Weiwei Zhao; Steven M Pogwizd
Journal:  Cardiovasc Res       Date:  2009-10-30       Impact factor: 10.787

7.  Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy.

Authors:  Fadi G Akar; David D Spragg; Richard S Tunin; David A Kass; Gordon F Tomaselli
Journal:  Circ Res       Date:  2004-09-02       Impact factor: 17.367

8.  In situ regulation of cell-cell communication by the cAMP-dependent protein kinase and protein kinase C.

Authors:  A J Godwin; L M Green; M P Walsh; J R McDonald; D A Walsh; W H Fletcher
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

9.  Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions.

Authors:  B R Kwak; H J Jongsma
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

Review 10.  Remodelling of gap junctions and connexin expression in diseased myocardium.

Authors:  Nicholas J Severs; Alexandra F Bruce; Emmanuel Dupont; Stephen Rothery
Journal:  Cardiovasc Res       Date:  2008-06-02       Impact factor: 10.787

View more
  22 in total

Review 1.  Serine/Threonine Phosphatases in Atrial Fibrillation.

Authors:  Jordi Heijman; Shokoufeh Ghezelbash; Xander H T Wehrens; Dobromir Dobrev
Journal:  J Mol Cell Cardiol       Date:  2017-01-07       Impact factor: 5.000

2.  Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.

Authors:  Sean T DeGrande; Sean C Little; Derek J Nixon; Patrick Wright; Jedidiah Snyder; Wen Dun; Nathaniel Murphy; Ahmet Kilic; Robert Higgins; Philip F Binkley; Penelope A Boyden; Cynthia A Carnes; Mark E Anderson; Thomas J Hund; Peter J Mohler
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

Review 3.  Regulation of cardiac gap junctions by protein phosphatases.

Authors:  Ashleigh R Hood; Xun Ai; Steven M Pogwizd
Journal:  J Mol Cell Cardiol       Date:  2017-05-03       Impact factor: 5.000

Review 4.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 5.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 6.  Roles and regulation of protein phosphatase 2A (PP2A) in the heart.

Authors:  Ellen R Lubbers; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2016-11-08       Impact factor: 5.000

7.  A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells.

Authors:  Karl Staser; Matthew A Shew; Elizabeth G Michels; Muithi M Mwanthi; Feng-Chun Yang; D Wade Clapp; Su-Jung Park
Journal:  Exp Hematol       Date:  2012-10-11       Impact factor: 3.084

8.  Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1.

Authors:  Jaime DeSantiago; Dan J Bare; Yunbo Ke; Katherine A Sheehan; R John Solaro; Kathrin Banach
Journal:  J Mol Cell Cardiol       Date:  2013-04-20       Impact factor: 5.000

Review 9.  Role of p21-activated kinases in cardiovascular development and function.

Authors:  Mollie L Kelly; Artyom Astsaturov; Jonathan Chernoff
Journal:  Cell Mol Life Sci       Date:  2013-05-04       Impact factor: 9.261

Review 10.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.